Table 2.
Anthropometric parameters, clinical conditions, scores of International Physical Activity Questionnaire (IPAQ), and physical fitness tests in non-exercising (NPE) and exercising (PE) older women pre-supplementation with L-glutamine or placebo for 30 days. (* p < 0.05).
| Characteristics | NPE (n = 23) | PE (n = 21) | p Value |
|---|---|---|---|
| Age (year) | 68.6 ± 4.5 | 69.8 ± 4.8 | >0.05 |
| Height (cm) | 155 ± 6.1 | 155 ± 6.5 | >0.05 |
| Weight (kg) | 64.1 ± 8.1 | 59.6 ± 10.5 | >0.05 |
| Body mass index (kg/m2) | 26.5 ± 3.4 | 24.6 ± 3.1 | >0.05 |
| Total body fat (%) | 40.3 ± 7.3 | 43.8 ± 6.8 | >0.05 |
| ASM/height (kg/m) | 4.4 ± 0.6 | 6.1 ± 0.3 | >0.05 |
| Clinical conditions | |||
| (based on medications use) | |||
| Diabetes mellitus, n(%) | 3(13) | 2(10) | >0.05 |
| Dyslipidemia, n(%) | 6(26) | 6(29) | >0.05 |
| Hypertension, n(%) | 9(39) | 8(38) | >0.05 |
| Coronary heart diseases, n(%) | 1(4) | 1(5) | >0.05 |
| Osteoarthritis, n(%) | 4(17) | 0(0) * | <0.05 |
| Depression, n(%) | 6(26) | 0(0) * | <0.05 |
| Hypothyroidism, n(%) | 4(17) | 3(14) | >0.05 |
| IPAQ | |||
| Low level | 497 ± 83 | 886 ± 175 * | <0.05 |
| Moderate level | 413 ± 112 | 1006 ± 263 * | <0.05 |
| High level | 318 ± 70 | 409 ± 121 | >0.05 |
| Sitting time (min/wk) | 1745 ± 242 | 1169 ± 90 * | <0.05 |
| Functional Fitness Tests | |||
| TUGT a (s) | 8.4 ± 1.0 | 6.8 ± 1.2 * | <0.05 |
| 5X ST b (s) | 11.0 ± 2.3 | 11.0 ± 1.5 | >0.05 |
a TUGT, timed up-and-go test; b 5XST, 5-times chair stand test.